Additional 100,000 vials of Remdesivir for COVID-19 treatment arrive in Vietnam
Approximately 100,000 vials of Remdesivir produced by Mylan pharmaceutical company under Pfizer group have arrived in Vietnam in order to treat COVID-19 patients.
Approximately 100,000 vials of Remdesivir produced by Mylan pharmaceutical company under Pfizer group have arrived in Vietnam in order to treat COVID-19 patients.
A Malaysian Airlines plane carrying 50,000 vials of Remdesivir, a much-sought-after drug to treat COVID-19 globally, touched down at Tan Son Nhat International Airport in Ho Chi Minh City late August 21.
Vingroup, a leading multi-sectoral conglomerate in Vietnam, has reached a deal with its partner to purchase 500,000 vials of Remdesivir, an antiviral drug licensed by the US Food and Drug Administration, for COVID-19 treatment in Vietnam.